Rosiglitazone maleate

製品コードS2505 バッチS250503

印刷

化学情報

 Chemical Structure Synonyms BRL-49653C, BRL-49653 Storage
(From the date of receipt)
3 years -20°C powder
1 years -80°C in solvent
化学式

C18H19N3O3S.C4H4O4

分子量 473.5 CAS No. 155141-29-0
Solubility (25°C)* 体外 DMSO 95 mg/mL (200.63 mM)
Ethanol 2 mg/mL (4.22 mM)
Water Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液(一定の濃度)を調合する

生物活性

製品説明 Rosiglitazone maleate, a member of the thiazolidinedione class of antihyperglycaemic agents, is a high-affinity selective agonist of the peroxisome proliferator-activated receptor-γ (PPAR-γ) with IC50 of 42 nM. Rosiglitazone maleate also modulates TRP channels and induces autophagy. Rosiglitazone prevents ferroptosis.
in vitro

Rosiglitazone is an insulin-sensitising agent of the thiazolidinedione class of oral antihyperglycaemic drugs. Rosiglitazone exhibits insulin-sensitising activity 60- to 200-fold higher than that of troglitazone, englitazone, or piogliazone in rodent models of insulin ressitance. Rosiglitazone reduces hyperglycaemia by improving insulin sensitivity in adipose tissue, the liver and skeletal muscle tissue. Such insulin sensitisation may be partly attributable to the effects of Rosiglitazone on the expression of molecules involved in the insulin signalling cascade. In adipose tissue, Rosiglitazone-mediated PPARγ stimulation promotes adipocyte differentiation. Rosiglitazone may also promote the uptake of free fatty acids in adipose tissue, thus reducing systemic free fatty acid levels. The insulin sensitivity of the liver and peripheral tissues may be modulated indirectly by Rosiglitazone-mediated changes in levels of fatty acid or adipocyte-derived factors, such as adiponectin and TNFα. Rosiglitazone may also be involved in modulating the expression of adiponectin receptors in some tissues, which may be relevant to some aspects of insulin sensitisation. [1]

プロトコル(参考用のみ)

カスタマーフィードバック

Data from [Mol Metab, 2013, 2(3), 215-26]

Data from [Stroke, 2013, 44(12), 3498-508]

, , Reprod Toxicol, 2016, 61:162-8

Selleckの高級品が、幾つかの出版された研究調査結果(以下を含む)で使われた:

Generation of functionally competent hepatic stellate cells from human stem cells to model liver fibrosis in vitro [ Stem Cell Reports, 2022, 17(11):2531-2547] PubMed: 36270282
Elaiophylin reduces body weight and lowers glucose levels in obese mice by activating AMPK [ Cell Death Dis, 2021, 12(11):972] PubMed: 34671010
Oxygen-sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension [ Antioxidants (Basel), 2021, 10(2)155] PubMed: 33494520
Low-intensity pulsed ultrasound prevents angiotensin II-induced aortic smooth muscle cell phenotypic switch via hampering miR-17-5p and enhancing PPAR-γ [ Eur J Pharmacol, 2021, 911:174509] PubMed: 34547245
Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ [ Front Cardiovasc Med, 2021, 8:698056] PubMed: 34336956
Inhibition of the activation of γδT17 cells through PPARγ-PTEN/Akt/GSK3β/NFAT pathway contributes to the anti-colitis effect of madecassic acid [ Cell Death Dis, 2020, 11(9):752] PubMed: 32929062
Peroxisome proliferator-activated receptor γ (PPARγ) suppresses the proliferation and metastasis of patients with urothelial carcinoma after renal transplantation by inhibiting LEF1/β-catenin signaling [ Bioengineered, 2020, 11(1):1350-1367] PubMed: 33289586
Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion [ FASEB J, 2020, 10.1096/fj.202001758R] PubMed: 33070393
TRIM27-mediated ubiquitination of PPARγ promotes glutamate-induced cell apoptosis and inflammation [ Exp Cell Res, 2020, S0014-4827(20)30690-X] PubMed: 33385414
Upregulation of FABP7 inhibits acute kidney injury-induced TCMK-1 cell apoptosis via activating the PPAR gamma signalling pathway [ Mol Omics, 2020, 16(6):533-542] PubMed: 33315023

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。